Both in Pharmaceuticals
Ensysce Biosciences vs Aprea Therapeutics
Over the past year ENSC returned −79.5% and APRE returned −68.0%; their daily moves had a correlation of 0.13.
ENSC −79.5% APRE −68.0%Growth of $1, one year, split-adjusted
| Metric | ENSC | APRE |
|---|---|---|
| Price | $0.5029 | $0.5323 |
| Market cap | $9.8M | $6.7M |
| Today | −2.97% | −8.88% |
| 1 month | +9.8% | −30.0% |
| 6 months | +3.9% | −45.7% |
| Year to date | −45.3% | −37.6% |
| 1 year | −80.4% | −65.4% |
| Revenue growth (YoY) | −15.1% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −220.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | 1,292.6× |
| Net cash | $479.9K | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 137.5% | 84.2% |
| Short % of float | 7.5% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).